John M Dye

20PUBLICATIONS
385CO-AUTHORS
Medical infection agents (incl. prions)Particle physicsInnate immunityMolecular targetsNon-genetically modified uses of biotechnology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 12, 2022
Phosphatidylserine clustering by the Ebola virus matrix protein is a critical step in viral budding.

Monica L Husby, Souad Amiar, Laura I Prugar

|Mar 16, 2022
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.

Eva Mittler, Anna Z Wec, Janne Tynell

|Feb 26, 2022
Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals.

Susan L Uprichard, Amornrat O'Brien, Monika Evdokimova

|Jan 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.

Yueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends

|Nov 17, 2021
Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.

Jens H Kuhn, Scott Adkins, Bernard R Agwanda

|Oct 26, 2021
On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization.

Brett F Beitzel, Sheli R Radoshitzky, Nicholas Di Paola

Pageof 4

Frequent Collaborators

10 joint publications

Kartik Chandran

8 joint publications

Jens H Kuhn

7 joint publications

Gaya K Amarasinghe

7 joint publications

Christopher F Basler